BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

20 related articles for article (PubMed ID: 38665025)

  • 1. Independent validation of CT radiomics models in colorectal liver metastases: predicting local tumour progression after ablation.
    van der Reijd DJ; Guerendel C; Staal FCR; Busard MP; De Oliveira Taveira M; Klompenhouwer EG; Kuhlmann KFD; Moelker A; Verhoef C; Starmans MPA; Lambregts DMJ; Beets-Tan RGH; Benson S; Maas M
    Eur Radiol; 2024 Jun; 34(6):3635-3643. PubMed ID: 37987835
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Percutaneous Radiofrequency Ablation of Colorectal Cancer Liver Metastases: Factors Affecting Outcomes--A 10-year Experience at a Single Center.
    Shady W; Petre EN; Gonen M; Erinjeri JP; Brown KT; Covey AM; Alago W; Durack JC; Maybody M; Brody LA; Siegelbaum RH; D'Angelica MI; Jarnagin WR; Solomon SB; Kemeny NE; Sofocleous CT
    Radiology; 2016 Feb; 278(2):601-11. PubMed ID: 26267832
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Magnetic Resonance Mediated Radiofrequency Ablation.
    Hue YK; Guimaraes AR; Cohen O; Nevo E; Roth A; Ackerman JL
    IEEE Trans Med Imaging; 2018 Feb; 37(2):417-427. PubMed ID: 28922117
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Early outcomes of radiofrequency ablation in unresectable metastatic colorectal cancer from a tertiary cancer hospital in India.
    Kulkarni S; Shetty NS; Polnaya AM; Patil S; Gala K; Chivate R; Ostwal V; Ramaswamy A; Shrikhande SV; Goel M; Patkar S; Bhandare M; Rangarajan V; Nilendu P
    Indian J Radiol Imaging; 2017; 27(2):200-206. PubMed ID: 28744081
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A predictive model using MRI and clinicopathologic features for breast cancer recurrence in young women treated with upfront surgery.
    Chae EY; Jung MR; Cha JH; Shin HJ; Choi WJ; Kim HH
    Eur Radiol; 2024 May; ():. PubMed ID: 38787429
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical outcomes of image-guided therapies in patients with adrenocortical carcinoma: a tertiary referral center retrospective study.
    Chahla B; Pal K; Balderrama-Brondani V; Yaylaci F; Campbell MT; Sheth RA; Habra MA
    Oncologist; 2024 Jun; ():. PubMed ID: 38869364
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Single-Center Retrospective Analysis of Periprocedural Variables Affecting Local Tumor Progression after Radiofrequency Ablation of Colorectal Cancer Liver Metastases.
    Han K; Kim JH; Yang SG; Park SH; Choi HK; Chun SY; Kim PN; Park J; Lee M
    Radiology; 2021 Jan; 298(1):212-218. PubMed ID: 33170105
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Radiomics complements clinical, radiological, and technical features to assess local control of colorectal cancer lung metastases treated with radiofrequency ablation.
    Markich R; Palussière J; Catena V; Cazayus M; Fonck M; Bechade D; Buy X; Crombé A
    Eur Radiol; 2021 Nov; 31(11):8302-8314. PubMed ID: 33954806
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The value of KRAS gene status in predicting local tumor progression of colorectal liver metastases following radiofrequency ablation.
    Jiang BB; Yan K; Zhang ZY; Yang W; Wu W; Yin SS; Chen MH
    Int J Hyperthermia; 2019 Jan; 36(1):211-219. PubMed ID: 30663903
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of pulmonary colorectal metastases by radiofrequency ablation.
    Petre EN; Jia X; Thornton RH; Sofocleous CT; Alago W; Kemeny NE; Solomon SB
    Clin Colorectal Cancer; 2013 Mar; 12(1):37-44. PubMed ID: 23026111
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Local tumor progression patterns after radiofrequency ablation of colorectal cancer liver metastases.
    Napoleone M; Kielar AZ; Hibbert R; Saif S; Kwan BY
    Diagn Interv Radiol; 2016; 22(6):548-554. PubMed ID: 27705879
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Local Tumor Progression Predictive Model Based on MRI for Colorectal Cancer Liver Metastases after Radiofrequency Ablation.
    Zhang G; Liu P; Wang G; He X; Xu L; Wang Y; Li W; Peng W
    Discov Med; 2024 Apr; 36(183):765-777. PubMed ID: 38665025
    [TBL] [Abstract][Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 1.